On June 30, 2026, the European Commission (EC) announced the opening of a formal antitrust investigation into Align Technology, the company behind Invisalign clear aligners and iTero intra-oral scanners. The EC will assess whether Align Technology may have abused its dominant position in the EEA by tying its intra-oral scanners to its dental aligners.
The case is significant as it represents the EC’s first formal antitrust investigation in the medical devices sector and follows a complaint by a competitor.
Focus of the investigation
Align Technology is a U.S.-based medical device company, best known for two leading products: Invisalign clear aligners, used to correct teeth misalignment, and iTero intra-oral scanners, which enable dental professionals to create 3D digital scans of patients’ teeth and jaws.